4.4 Article

Gingival crevicular fluid levels of monocyte chemoattractant protein-1 in periodontal health and disease

Journal

ARCHIVES OF ORAL BIOLOGY
Volume 54, Issue 5, Pages 503-509

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.archoralbio.2009.02.007

Keywords

Gingival crevicular fluid; Monocyte chemoattractant protein-1; Periodontal health; Gingivitis; Chronic periodontitis; Scaling and root planing

Ask authors/readers for more resources

Objectives: Monocyte chemoattractant protein-1 (MCP-1) stimulates the chemotaxis of monocytes and also several cellular events associated with chemotaxis thus causes recruitment of inflammatory cells. Its increased gingival crevicular fluid (GCF) levels in periodontal disease have been reported in previous studies. The present study has been carried out to assess the role of MCP-1 in periodontal disease progression and also to determine the effect of periodontal treatment on MCP-1 concentration in GCF. Design: A total of 60 subjects were divided into three groups (n = 20) based on gingival index (GI), probing pocket depth (PPD) and clinical attachment loss (CAL): healthy (group I), gingivitis (group II) and chronic periodontitis (group III). A fourth group (group M consisted of 20 subjects from group III, 6-8 weeks after treatment (i.e. scaling and root planing). GCF samples collected from each patient were quantified for MCP-1 using ELISA. Results: The mean MCP-1 concentration in GCF was found to be the highest in group III, i.e. 72.60 pg/mu l. The mean MCP-1 concentration in group I was 19.70 pg/mu l and in group IV was 8.50 pg/mu l. The mean MCP-1 concentration (37.00 pg/mu l) in group II was found to lie in between the concentrations obtained in groups I and III. Conclusions: GCF MCP-1 levels increased progressively with the progression of disease and decreased after treatment. Levels of MCP-1 correlated positively with clinical parameters like GI, PPD and CAL thus it can be considered as an inflammatory biomarker in periodontal disease and also deserves further consideration as a therapeutic target. (C) 2009 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available